US Stock MarketDetailed Quotes

ONCO Onconetix

Watchlist
  • 0.167
  • -0.038-18.40%
Close Jun 28 16:00 ET
  • 0.159
  • -0.008-4.90%
Post 19:57 ET
3.73MMarket Cap-66P/E (TTM)

About Onconetix Company

Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company was founded in October 2018 and is headquartered in Cincinnati, OH.

Company Profile

SymbolONCO
Company NameOnconetix
Listing DateFeb 18, 2022
Founded2018
CEODr. Ralph Schiess
MarketNASDAQ
Employees23
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address201 East 5th Street,Suite 1900
CityCincinnati
ProvinceOhio
CountryUnited States of America
Zip Code45202
Phone1-513-620-4101
Websitehttp://www.onconetix.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Ralph Schiess
  • Chief Science Officer and Interim Chief Executive Officer
  • --
  • Karina M. Fedasz
  • Interim Chief Financial Officer
  • --
  • Christian Bruhlmann
  • Chief Strategy Officer
  • --
  • James Sapirstein
  • Non-Executive Chairman of the Board and Lead Independent Director
  • --
  • Dr. Thomas Meier, PhD
  • Director
  • --
  • Dr. Ajit Singh, PhD.
  • Director
  • --
  • Timothy R. Ramdeen
  • Independent Director
  • --
  • Simon Tarsh
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg